Miriam V. Rivas

Miriam V. Rivas

Auto-generated profile, based on publicly available information

Miriam V. Rivas

Inotiv RTP Research Triangle Park North Carolina USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2023 in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Verified
Journal Article
Open access
SSStephanie L. Smith-Roe
Stephanie L. Smith-Roe
CHCheryl A. Hobbs
Cheryl A. Hobbs
VHVictoria Hull
Victoria Hull
JAJ. Todd Auman
J. Todd Auman
LRLeslie Recio
Leslie Recio
KWKristine Witt
Kristine Witt
Duplex sequencing (DS) is an error-corrected next-generation sequencing method in which molecular barcodes informatically link PCR-copies back to their source DNA strands, enabling computational removal of errors in consensus sequences. The resulting background of less than one artifactual mutation per 107 nucleotides allows for direct detection of somatic mutations. TwinStrand Biosciences, Inc. has developed a DS-based mutagenesis assay to sample the rat genome, which can be applied to genetic toxicity testing. To evaluate this assay for early detection of mutagenesis, a time-course study was conducted using male Hsd:Sprague Dawley SD rats (3 per group) administered a single dose of 40 mg/kg N-ethyl-N-nitrosourea (ENU) via gavage, with mutation frequency (MF) and spectrum analyzed in stomach, bone marrow, blood, and liver tissues at 3 h, 24 h, 7 d, and 28 d post-exposure. Significant increases in MF were observed in ENU-exposed rats as early as 24 h for stomach (site of contact) and bone marrow (a highly proliferative tissue) and at 7 d for liver and blood. The canonical, mutational signature of ENU was established by 7 d post-exposure in all four tissues. Interlaboratory analysis of a subset of samples from different tissues and time points demonstrated remarkable reproducibility for both MF and spectrum. These results demonstrate that MF and spectrum can be evaluated successfully by directly sequencing targeted regions of DNA obtained from various tissues⁠, a considerable advancement compared to currently used in vivo gene mutation assays.

22 February 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ECEunnara Cho
Eunnara Cho
CSCarol D. Swartz
Carol D. Swartz
AWAndrew Williams
Andrew Williams
MRMiriam Rivas
Miriam Rivas
LRLeslie Recio
Leslie Recio
CYCarole L. Yauk
Carole L. Yauk
Error-corrected Duplex Sequencing (DuplexSeq) enables direct quantification of low-frequency mutations and offers tremendous potential for chemical mutagenicity assessment. We investigated the utility of DuplexSeq to quantify induced mutation frequency (MF) and spectrum in human lymphoblastoid TK6 cells exposed to a prototypical DNA alkylating agent, N -ethyl- N -nitrosourea (ENU). Furthermore, we explored appropriate experimental parameters for this application, and assessed inter-laboratory reproducibility. In two independent experiments in two laboratories, TK6 cells were exposed to ENU (25-200 µM) and DNA was sequenced 48, 72, and 96 h post-exposure. A DuplexSeq mutagenicity panel targeting twenty 2.4-kb regions distributed across the genome was used to sample diverse, genome-representative sequence contexts. A robust increase in MF that was unaffected by time was observed in both laboratories. Concentration-response in the MF from the two laboratories was strongly positively correlated (R 2 =0.95). C:G>T:A, T:A>C:G, T:A>A:T, and T:A>G:C mutations increased in consistent, concentration-dependent manners in both laboratories, with high proportions of C:G>T:A at all time points. The target sites responded similarly between the two laboratories and revealed a higher average MF in intergenic regions. These results, demonstrating remarkable reproducibility across time and laboratory for both MF and spectrum, support the high value of DuplexSeq for characterizing chemical mutagenicity in both research and regulatory evaluation.

28 November 2025 in Genome Biology and Evolution
Verified
Journal Article
Open access
CLChul Lee
Chul Lee
SCSeoae Cho
Seoae Cho
KKKyu-Won Kim
Kyu-Won Kim
DYDongahn Yoo
Dongahn Yoo
MDMatthew Davenport
Matthew Davenport
EJErich D Jarvis
Erich D Jarvis
Vocal learning, the ability to imitate sounds, is a complex convergent trait crucial for spoken language and observed in a few independent lineages of mammals and birds. While convergences in gene expression have been found in vocal learning brain regions, amino acid convergences remain unclear. Here, we investigated whether avian vocal learning clades have amino acid convergences linked to their specialized trait. We developed a tool, Convergent Variant Finder, and applied it to an alignment of 48 species representing nearly all bird orders to identify convergent single amino acid variants among vocal learners and over 8,000 other polyphyletic species combinations. We discovered that the number of convergent variants was associated with the product of branch lengths of the most recent common ancestors of each species combination. The number of convergent variants in vocal learning clades did not exceed that of control species combinations. However, a subset of genes with vocal learner–specific convergent amino acid variants was enriched in the “learning” process, under positive selection, and significantly overlapped with gene sets for FOXP2 targets, singing-induced regulation in vocal learning nuclei, and differentially expressed in vocal learning nuclei. Moreover, we confirmed that the majority of convergent patterns in vocal learners were in the genomes of 363 species densely sampled across the avian tree. We propose that amino acid and nucleotide convergence accumulates at a steady state, with the rate proportional to divergence time. Selection associated with convergent traits, such as vocal learning, then likely acts on a subset of these changes.

11 June 2026 in Environmental and Molecular Mutagenesis
Verified
Journal Article
Open access
XZXinwen Zhang
Xinwen Zhang
CHCheryl A. Hobbs
Cheryl A. Hobbs
MRMiriam V. Rivas
Miriam V. Rivas
ADAlex Diesing
Alex Diesing
DLDanielle P. M. LeBlanc
Danielle P. M. LeBlanc
SSStephanie L. Smith‐Roe
Stephanie L. Smith‐Roe
Polycyclic aromatic hydrocarbons (PAHs) are well‐known for their mutagenic and carcinogenic effects. Benzo[ b ]fluoranthene (BbF) is one of 16 PAHs prioritized by the US Environmental Protection Agency for toxicological evaluation due to pervasive human exposure. As part of a multi‐stakeholder consortium, the genotoxic effects of BbF were evaluated in MutaMouse males exposed to five doses of BbF or a vehicle control via repeated oral gavage for 28, 60, 90, 120, or 180 days, with dose ranges adjusted by duration of exposure. Mutagenesis was evaluated in lung tissue ( n = 4) at 28, 90, and 180 days using Duplex Sequencing (DS), and chromosomal damage ( n = 8) was evaluated using the micronucleus assay in peripheral blood at all time points. Dose‐ and time‐dependent increases in total mutation frequency (MF) and C:G > A:T mutations were observed in lung tissue after 28, 90, and 180 days of exposure. By 28 days, BbF exposure produced lung cancer‐associated mutational signatures linked to tobacco smoking. Mutations accumulated over time in lung, whereas chromosomal damage in peripheral blood erythrocytes reached a steady state by 28 days. Benchmark dose (BMD) confidence intervals (CIs) narrowed with extended exposure only for MF. Collectively, the data demonstrate that BbF is a potent mutagen capable of inducing cancer‐relevant mutations in lung, supporting its potential role in human lung carcinogenesis. By distinguishing early mutagenic responses from cumulative mutation effects over time, these findings highlight the value of integrating mutagenicity assessment into extended‐duration studies to better inform the potential health effects of chronic genotoxic exposures.